S&P 500

5.464,62

-0,16%

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

BAX Baxter International Inc

34,29

0,29 (0,85%)

22 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

null

Baxter (NYSE:BAX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Baxter (NYSE:BAX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

News Baxter International Inc

Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
Donnerstag 6 Juni 2024 (2 Wochen vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 Juni 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form SD - Specialized disclosure report
Freitag 31 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Mittwoch 29 Mai 2024 (4 Wochen vor) • Business Wire

Baxter to Present at Jefferies 2024 Global Healthcare Conference
Donnerstag 23 Mai 2024 (1 Monat vor) • Business Wire

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Mittwoch 15 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive
Mittwoch 15 Mai 2024 (1 Monat vor) • Business Wire

Baxter Secures FDA Approval of Clinolipid (Lipid Injectable Emulsion) Neonatal and Pediatric Indication
Montag 13 Mai 2024 (1 Monat vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 9 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Baxter International Inc News-Artikel

Societe Generale Effekten

USOTC

SMWFF

SSGA SPDR Etfs Europe II (PK)

NASDAQI

SX502060GI

OMX Stockholm Industrial...

NLBNPIT1ZPS8 20241220 200

UBS Irl Fund Solutions

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

BAX Baxter International Inc

News Baxter International Inc

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

BAX Baxter International Inc

News Baxter International Inc

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen